1. Home
  2. EIC vs XOMA Comparison

EIC vs XOMA Comparison

Compare EIC & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EIC
  • XOMA
  • Stock Information
  • Founded
  • EIC N/A
  • XOMA 1981
  • Country
  • EIC United States
  • XOMA United States
  • Employees
  • EIC N/A
  • XOMA N/A
  • Industry
  • EIC Finance/Investors Services
  • XOMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • EIC Finance
  • XOMA Health Care
  • Exchange
  • EIC Nasdaq
  • XOMA Nasdaq
  • Market Cap
  • EIC 348.9M
  • XOMA 330.2M
  • IPO Year
  • EIC 2019
  • XOMA N/A
  • Fundamental
  • Price
  • EIC $13.86
  • XOMA $32.47
  • Analyst Decision
  • EIC Strong Buy
  • XOMA Strong Buy
  • Analyst Count
  • EIC 1
  • XOMA 2
  • Target Price
  • EIC $17.50
  • XOMA $69.50
  • AVG Volume (30 Days)
  • EIC 234.9K
  • XOMA 57.0K
  • Earning Date
  • EIC 08-12-2025
  • XOMA 08-13-2025
  • Dividend Yield
  • EIC 11.24%
  • XOMA N/A
  • EPS Growth
  • EIC N/A
  • XOMA N/A
  • EPS
  • EIC 0.70
  • XOMA N/A
  • Revenue
  • EIC $55,581,156.00
  • XOMA $44,952,000.00
  • Revenue This Year
  • EIC $37.84
  • XOMA $82.30
  • Revenue Next Year
  • EIC $23.33
  • XOMA $12.59
  • P/E Ratio
  • EIC $19.94
  • XOMA N/A
  • Revenue Growth
  • EIC 56.39
  • XOMA 194.98
  • 52 Week Low
  • EIC $12.10
  • XOMA $18.35
  • 52 Week High
  • EIC $16.71
  • XOMA $35.23
  • Technical
  • Relative Strength Index (RSI)
  • EIC 70.39
  • XOMA 61.79
  • Support Level
  • EIC $12.10
  • XOMA $32.60
  • Resistance Level
  • EIC $13.15
  • XOMA $34.60
  • Average True Range (ATR)
  • EIC 0.18
  • XOMA 1.82
  • MACD
  • EIC 0.13
  • XOMA 0.09
  • Stochastic Oscillator
  • EIC 97.37
  • XOMA 66.75

About EIC Eagle Point Income Company Inc.

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: